The US FDA may be able to use the International Conference on Harmonization to align generic drug standards around the world and by extension potentially lower development and patient costs.
ICH, which comprises representatives of many international regulators and is focused on creating common drug development standards, wants to move into the generic drug space
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?